Aligned Genetics Inc (238120) — Financial Flexibility Index
Aligned Genetics Inc (238120) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of ₩-2.00 Billion (operating CF ₩-2.04 Billion minus capex ₩41.78 Million) represents 0% of total liabilities (₩9.61 Billion). Check how strategically is Aligned Genetics Inc's equity deployed to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aligned Genetics Inc Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Aligned Genetics Inc across 10 annual periods. See 238120 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Aligned Genetics Inc (2015–2024)
Year-by-year free cash flow to debt coverage for Aligned Genetics Inc. For the full company profile including market capitalisation, see market value of Aligned Genetics Inc.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.39x | ₩3.41 Billion | ₩3.07 Billion | ₩8.78 Billion | ▲ +0.1% |
| 2023 | 0.39x | ₩3.73 Billion | ₩2.85 Billion | ₩9.62 Billion | ▼ -26.1% |
| 2022 | 0.52x | ₩4.22 Billion | ₩2.22 Billion | ₩8.05 Billion | ▲ +13.9% |
| 2021 | 0.46x | ₩3.44 Billion | ₩135.97 Million | ₩7.48 Billion | ▲ +1300.5% |
| 2020 | 0.03x | ₩132.11 Million | ₩35.67 Million | ₩4.02 Billion | ▼ -87.0% |
| 2019 | 0.25x | ₩920.91 Million | ₩659.29 Million | ₩3.65 Billion | ▲ +134.7% |
| 2018 | -0.73x | ₩-1.53 Billion | ₩-1.75 Billion | ₩2.11 Billion | ▼ -156.9% |
| 2017 | -0.28x | ₩-471.30 Million | ₩-876.75 Million | ₩1.67 Billion | ▼ -72.4% |
| 2016 | -0.16x | ₩-275.21 Million | ₩-1.14 Billion | ₩1.68 Billion | ▼ -278.6% |
| 2015 | 0.09x | ₩73.12 Million | ₩-351.72 Million | ₩796.04 Million | — |